Biblio
“Cerebrospinal Fluid Anti-Amyloid-β Autoantibodies and Amyloid PET in Cerebral Amyloid Angiopathy-Related Inflammation.”, J Alzheimers Dis, vol. 50, no. 1, pp. 1-7, 2016.
, “MAPT H1 Haplotype is Associated with Late-Onset Alzheimer's Disease Risk in APOEɛ4 Noncarriers: Results from the Dementia Genetics Spanish Consortium.”, J Alzheimers Dis, vol. 49, no. 2, pp. 343-52, 2016.
, “Non-Fibrillar Oligomeric Amyloid-β within Synapses.”, J Alzheimers Dis, vol. 53, no. 3, pp. 787-800, 2016.
, “Progranulin Protein Levels in Cerebrospinal Fluid in Primary Neurodegenerative Dementias.”, J Alzheimers Dis, vol. 50, no. 2, pp. 539-46, 2016.
, “A Common Variant in the MC1R Gene (p.V92M) is associated with Alzheimer's Disease Risk.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1065-1074, 2017.
, “Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 3, pp. 909-918, 2017.
, “Feasibility of Lumbar Puncture in the Study of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Subjects with Down Syndrome.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1489-1496, 2017.
, “Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes.”, J Alzheimers Dis, vol. 56, no. 2, pp. 543-555, 2017.
, “Kidins220 Correlates with Tau in Alzheimer's Disease Brain and Cerebrospinal Fluid.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1327-1333, 2017.
, “MicroRNA Profile in Patients with Alzheimer's Disease: Analysis of miR-9-5p and miR-598 in Raw and Exosome Enriched Cerebrospinal Fluid Samples.”, J Alzheimers Dis, vol. 57, no. 2, pp. 483-491, 2017.
, “Clinical Subtypes of Dementia with Lewy Bodies Based on the Initial Clinical Presentation.”, J Alzheimers Dis, vol. 64, no. 2, pp. 505-513, 2018.
, “Quantitative Genetics Validates Previous Genetic Variants and Identifies Novel Genetic Players Influencing Alzheimer's Disease Cerebrospinal Fluid Biomarkers.”, J Alzheimers Dis, vol. 66, no. 2, pp. 639-652, 2018.
, “Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology.”, J Alzheimers Dis, vol. 77, no. 3, pp. 1353-1368, 2020.
, “Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort.”, J Alzheimers Dis, vol. 74, no. 1, pp. 213-225, 2020.
, “Different Inflammatory Signatures in Alzheimer's Disease and Frontotemporal Dementia Cerebrospinal Fluid.”, J Alzheimers Dis, vol. 81, no. 2, pp. 629-640, 2021.
,